This Biotech Stock Flew Higher On Likely CBD Oil Approval in Europe

GW Pharmaceuticals stock leapt higher Friday after European officials adopted a positive opinion of its CBD oil seizure treatment, a drug to be sold under the brand name Epidyolex. Read More...